Gene therapies, CRISPR drugs slowed by ‘irrational pessimism,’ scientists say

The darker period for gene therapies, in one scientist's estimation, is an overcorrection for the irrational exuberance of an earlier time.

March 20, 2025 Check out STAT+

Sponsored By

Brooke Alexander for STAT STAT+ | Gene therapies and CRISPR drugs slowed by 'irrational pessimism,' say scientists forging new paths This darker period for gene therapies, in Jim Wilson's estimation, is an overcorrection for the irrational exuberance of an earlier time By Eric Boodman and Katie Palmer STAT+ | HHS agency responsible for health care quality research threatened with mass layoffs Insiders say the HHS agency, which focuses on the safety and practical use of health care, could experience staff cuts of 80% to 90%. By John Wilkerson Former CDC director Tom Frieden shares warning for RFK Jr. on measles outbreak Wavering on vaccines and slashing public health spending could allow the Texas measles outbreak to turn into a disaster, Frieden says. By Sarah Owermohle Brooke Alexander for STAT STAT+ | Tapping the potential of GLP-1 drugs requires integrated care and overcoming inequities, executives say At STAT's Breakthrough Summit East, the CEOs of Ro and Included Health said the the U.S. health care system poses obstacles to maximizing that potential. By Ed Silverman STAT+ | Device maker Zynex Medical under pressure from insurers, SEC filings show In a recent SEC filing, Zynex Medical said an insurer that's a major client was suspending payments and reviewing prior claims. By Lizzy Lawrence Opinion: How to protect the American egg supply from avian flu   With growing evidence that H5N1 bird flu will become a permanent presence, former FDA commissioner outlines measures to protect birds, egg prices. By Scott Gottlieb Adobe Opinion: Trump administration policies will create worse health care for intersex people like me Those of us who are intersex have always faced medical and social harm. But what is happening now is something altogether different. By Kimberly Zieselman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser